Faron Pharmaceuticals - Innovative medical solutions (Part 2)

They apparently have to comply with AIM regulations due to Faron’s dual listing. According to AIM, a disclosure is required at over 3% and then at every 1-percentage-point interval when moving up or down.

I was also wondering why HCM kept making threshold disclosures, but it apparently stems from those AIM regulations, which have different thresholds than in Finland.

2 Likes